Insider Shareholders with Direct Ownership of Gemini Therapeutics, Inc. (GMTX)
This section provides a comprehensive overview of the insiders with direct ownership of Gemini Therapeutics, Inc. (GMTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Gemini Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
851,450 | 0 | 3,558,426 $86.7 Million | 2 |
Jun 17, 2024
Added 10.48%
|
|
Fs Development Holdings, Llc
> 10% Shareholder |
4,870,250 | 0 | 2,928,750 $71.4 Million | 2 |
Feb 05, 2021
Added 50.0%
|
Atlas Venture Fund X, L.P.
> 10% Shareholder |
1,835,799 | 835,117 | 1,593,785 $38.8 Million | 11 |
Sep 16, 2023
Reduced 0.13%
|
Novo Holdings
> 10% Shareholder |
0 | 1,250,000 | 1,090,772 $26.6 Million | 1 |
Jun 28, 2023
Reduced 53.4%
|
Braden Michael Leonard
> 10% Shareholder |
55,000 | 22,500 | 247,500 $6.03 Million | 2 |
Oct 26, 2022
Reduced 8.33%
|
John D Quisel
Chief Executive Officer |
84,856 | 12,791 | 72,065 $1.76 Million | 5 |
Dec 16, 2024
Reduced 0.69%
|
William Jacob Savage
Chief Medical Officer |
66,746 | 46,666 | 40,405 $984,669 | 12 |
Nov 25, 2024
Reduced 4.5%
|
Pamela Stephenson
Chief Commercial Officer |
36,666 | 0 | 36,666 $893,550 | 1 |
Feb 26, 2024
Added 50.0%
|
Jean M. Franchi
Chief Financial Officer |
36,666 | 0 | 36,666 $893,550 | 1 |
Feb 07, 2024
Added 50.0%
|
Joanne Bryce
Chief Financial Officer |
40,847 | 20,634 | 23,665 $576,716 | 13 |
Jan 10, 2024
Added 43.43%
|
Jonathan Yen Wen Yu
Chief Business Officer |
18,165 | 0 | 18,165 $442,681 | 1 |
Jan 10, 2024
Added 50.0%
|
Brian Piekos
CFO |
17,615 | 0 | 17,615 $429,277 | 2 |
May 31, 2022
Added 36.12%
|
Rahul Khara
General Counsel |
29,035 | 15,000 | 14,035 $342,032 | 7 |
Jan 10, 2024
Added 50.0%
|
Jason Patrick Meyenburg
Chief Executive Officer |
13,000 | 0 | 13,000 $316,810 | 1 |
May 14, 2021
Added 50.0%
|
Brian Richard Mac Donald
Chief Innovation Officer |
600 | 14,524 | 12,276 $299,166 | 4 |
Jun 30, 2023
Added 4.66%
|
Orbimed Advisors Llc
Director |
1,724 | 1,724 | 0 $0 | 2 |
Dec 18, 2023
Reduced 100.0%
|
50,083 | 50,083 | 0 $0 | 22 |
Dec 02, 2024
Reduced 100.0%
|
|
Mona Ashiya
Director |
1,724 | 1,724 | 0 $0 | 2 |
Dec 18, 2023
Reduced 100.0%
|